128 related articles for article (PubMed ID: 12409964)
1. Increased sensitivity of the obese Zucker rat to deoxycorticosterone-salt-induced hypertension.
Morrison RG; Carpenter AB; Moore SK; Mangiarua EI; Valentovic MA; Walker EM; Wehner PS; Rhoten WB; Touchon RC; McCumbee WD
J Hypertens; 2002 Nov; 20(11):2247-55. PubMed ID: 12409964
[TBL] [Abstract][Full Text] [Related]
2. Obesity induced renal oxidative stress contributes to renal injury in salt-sensitive hypertension.
Quigley JE; Elmarakby AA; Knight SF; Manhiani MM; Stepp DW; Olearzcyk JJ; Imig JD
Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):724-8. PubMed ID: 19207724
[TBL] [Abstract][Full Text] [Related]
3. DOCA stimulates salt appetite in Zucker rats: effect of dose, synergistic action with central angiotensin II, and obesity.
Omouessi ST; Falconetti C; Fernette B; Thornton SN
Brain Res Bull; 2007 Sep; 74(1-3):14-20. PubMed ID: 17683784
[TBL] [Abstract][Full Text] [Related]
4. Sodium butyrate ameliorates deoxycorticosterone acetate/salt-induced hypertension and renal damage by inhibiting the MR/SGK1 pathway.
Wu C; Chen Z; Zhang L; Zhu Y; Deng M; Huang C; Liu Y; Zhu Q; Wang L
Hypertens Res; 2021 Feb; 44(2):168-178. PubMed ID: 32908237
[TBL] [Abstract][Full Text] [Related]
5. Dietary chloride does not correlate with urinary thromboxane in deoxycorticosterone acetate-treated rats.
Theriot JA; Passmore JC; Jimenez AE; Fleming JT
J Lab Clin Med; 2000 Jun; 135(6):493-7. PubMed ID: 10850649
[TBL] [Abstract][Full Text] [Related]
6. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.
Matsumura Y; Hashimoto N; Taira S; Kuro T; Kitano R; Ohkita M; Opgenorth TJ; Takaoka M
Hypertension; 1999 Feb; 33(2):759-65. PubMed ID: 10024341
[TBL] [Abstract][Full Text] [Related]
7. Chronic activation of central alpha2-adrenoceptors prevents hypertension in DOCA-salt rats.
Cabral AM; da Silva IF; Gardioli CR; Menegaz RG
Auton Neurosci; 2000 Aug; 82(3):146-53. PubMed ID: 11023621
[TBL] [Abstract][Full Text] [Related]
8. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
Rahmouni K; Sibug RM; De Kloet ER; Barthelmebs M; Grima M; Imbs JL; De Jong W
Eur J Pharmacol; 2002 Feb; 436(3):207-16. PubMed ID: 11858800
[TBL] [Abstract][Full Text] [Related]
9. Effects of soy protein isolate feeding on severe kidney damage in DOCA salt-treated obese Zucker rats.
Asanoma M; Tachibana N; Hirotsuka M; Kohno M; Watanabe Y
J Agric Food Chem; 2012 May; 60(21):5367-72. PubMed ID: 22553937
[TBL] [Abstract][Full Text] [Related]
10. Progression of renal damage in the obese Zucker rat in response to deoxycorticosterone acetate-salt-induced hypertension.
Morrison RG; Carpenter AB; Adams VL; Mangiarua EI; Wehner PS; McCumbee WD
Ann Clin Lab Sci; 2005; 35(1):54-65. PubMed ID: 15830710
[TBL] [Abstract][Full Text] [Related]
11. Blood pressure and renal responses to synthetic rat atrial natriuretic factor in deoxycorticosterone acetate-salt hypertension.
Kohzuki M; Abe K; Yasujima M; Kasai Y; Hiwatari M; Kanazawa M; Sato M; Omata K; Kudo K; Takeuchi K
Tohoku J Exp Med; 1989 Apr; 157(4):301-11. PubMed ID: 2525826
[TBL] [Abstract][Full Text] [Related]
12. Anakinra reduces blood pressure and renal fibrosis in one kidney/DOCA/salt-induced hypertension.
Ling YH; Krishnan SM; Chan CT; Diep H; Ferens D; Chin-Dusting J; Kemp-Harper BK; Samuel CS; Hewitson TD; Latz E; Mansell A; Sobey CG; Drummond GR
Pharmacol Res; 2017 Feb; 116():77-86. PubMed ID: 27986554
[TBL] [Abstract][Full Text] [Related]
13. Triptolide attenuates renal damage by limiting inflammatory responses in DOCA-salt hypertension.
Zhang J; Zhu M; Zhang S; Xie S; Gao Y; Wang Y
Int Immunopharmacol; 2020 Dec; 89(Pt A):107035. PubMed ID: 33045566
[TBL] [Abstract][Full Text] [Related]
14. A moderately high fat diet promotes salt-sensitive hypertension in obese zucker rats by impairing nitric oxide production.
Morrison RG; Mills C; Moran AL; Walton CE; Sadek MH; Mangiarua EI; Wehner PS; McCumbee WD
Clin Exp Hypertens; 2007 Aug; 29(6):369-81. PubMed ID: 17729054
[TBL] [Abstract][Full Text] [Related]
15. Role of the monocyte chemoattractant protein-1/C-C chemokine receptor 2 signaling pathway in transient receptor potential vanilloid type 1 ablation-induced renal injury in salt-sensitive hypertension.
Wang Y; Zhu M; Xu H; Cui L; Liu W; Wang X; Shen S; Wang DH
Exp Biol Med (Maywood); 2015 Sep; 240(9):1223-34. PubMed ID: 25585624
[TBL] [Abstract][Full Text] [Related]
16. Does the Sabra hypertension-prone rat represent a model of salt or mineralocorticoid sensitivity?
Yagil Y; Yagil C
J Hypertens; 1998 Oct; 16(10):1481-4. PubMed ID: 9814619
[TBL] [Abstract][Full Text] [Related]
17. Effects of alpha-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats.
Takaoka M; Kobayashi Y; Yuba M; Ohkita M; Matsumura Y
Eur J Pharmacol; 2001 Jul; 424(2):121-9. PubMed ID: 11476758
[TBL] [Abstract][Full Text] [Related]
18. Central vasopressin is required for the complete development of deoxycorticosterone-salt hypertension in rats with hereditary diabetes insipidus.
Liang J; Toba K; Ouchi Y; Nagano K; Akishita M; Kozaki K; Ishikawa M; Eto M; Orimo H
J Auton Nerv Syst; 1997 Jan; 62(1-2):33-9. PubMed ID: 9021647
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive effects of chicken extract against deoxycorticosterone acetate-salt-induced hypertension in rats.
Matsumura Y; Okui T; Ono H; Kiso Y; Tanaka T
Biol Pharm Bull; 2001 Oct; 24(10):1181-4. PubMed ID: 11642328
[TBL] [Abstract][Full Text] [Related]
20. Renal protective effects of N-acetyl-Ser-Asp-Lys-Pro in deoxycorticosterone acetate-salt hypertensive mice.
Rhaleb NE; Pokharel S; Sharma U; Carretero OA
J Hypertens; 2011 Feb; 29(2):330-8. PubMed ID: 21052020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
